NASDAQ:IVTY Invuity (IVTY) Stock Price, News & Analysis → why 99.94% won’t make you money (From Prosper Trading Academy) (Ad) Free IVTY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$7.39▼$7.3950-Day Range N/A52-Week Range$2.35▼$9.55VolumeN/AAverage Volume324,995 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Invuity alerts: Email Address Ad Paradigm PressMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. About Invuity Stock (NASDAQ:IVTY)Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities. It offers various illuminated surgical devices, including Eikon LT illuminated retractor system for breast/oncoplastic/gynecology/EP/plastic/endocrine surgeries; Eiberg illuminated retractor systems for orthopedic surgeries; PhotonBlade, a recision illuminator for breast/plastics/EP/orthopedics surgeries; PhotonSaber Y, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general/gynecology/plastic surgeries; and PhotonSaber F, a handheld illuminator for spine/orthopedic/neurosurgery surgeries. The company also provides Breiten illuminated retractor systems for spine/orthopedic surgeries; Photonguide XT system, a drop-in intracavity illuminator for spine surgeries; Eika illuminated retractor systems for endocrine/spine/orthopedic surgeries; and PhotonVue, a system used in conjunction with IC Indocyanine for identifying and verifying blood flow in tissue, as well as is used in breast/plastic/colorectal surgeries. It sells its devices through direct sales representatives and independent sales agents; and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. The company was formerly known as Spotlight Surgical, Inc. and changed its name to Invuity, Inc. in 2007. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California.Read More Ad Paradigm PressMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. IVTY Stock News HeadlinesOctober 28, 2023 | foxnews.comTop law firm rescinds job offers to Ivy League students who signed letter blaming Israel for violenceOctober 23, 2023 | usatoday.comIvy Queen receives Billboard Icon Award, reflects on difficult road to reggaeton successJune 18, 2024 | Paradigm Press (Ad)Discover How to Turn $10,000 into $1 MillionToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.September 27, 2023 | usatoday.comKelly Rowland says she's 'very proud' of Blue Ivy amid performance's for Beyoncé's tourAugust 16, 2023 | nypost.comThis top college consultant gets students into the Ivy League for $1.5K per hourAugust 10, 2023 | thestreet.comStudy: Ivy League Colleges Aren’t Worth ItJune 16, 2023 | mirror.co.ukBeyonce and Jay Z's 'billion dollar baby' as they launch Blue Ivy's performing careerJune 13, 2023 | mirror.co.ukBeyoncé and Jay-Z's daughter Blue Ivy is 'a billion-dollar baby waiting for her moment'June 18, 2024 | Paradigm Press (Ad)Discover How to Turn $10,000 into $1 MillionToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.March 13, 2023 | nypost.comPrinceton vs. Penn pick, odds: Take favorite in this Ivy League clashFebruary 24, 2023 | finance.yahoo.comFLG Partners Increases Capacity for GrowthFebruary 20, 2023 | mirror.co.ukJay-Z and Blue Ivy, 11, in rare appearance together as youngster looks all grown upSee More Headlines Receive IVTY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invuity and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/02/2018Today6/17/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & Medical Instruments Sub-IndustryN/A Current SymbolNASDAQ:IVTY CUSIPN/A CIK1393020 Webwww.invuity.com Phone415-655-2100FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Scott D. Flora (Age 62)Interim Pres, CEO & Director Mr. Philip M. Sawyer (Age 53)CEO, Pres & Director Mr. James H. MacKaness (Age 54)Chief Financial Officer Mr. Douglas W. Heigel (Age 57)Sr. VP of Operations Ms. Marcia Fish (Age 54)Chief HR Officer Key CompetitorsNyxoahNASDAQ:NYXHStevanato GroupNYSE:STVNStrykerNYSE:SYKBoston ScientificNYSE:BSXBecton, Dickinson and CompanyNYSE:BDXView All Competitors IVTY Stock Analysis - Frequently Asked Questions How were Invuity's earnings last quarter? Invuity, Inc. (NASDAQ:IVTY) issued its quarterly earnings results on Thursday, August, 2nd. The medical instruments supplier reported ($0.37) earnings per share for the quarter, beating the consensus estimate of ($0.47) by $0.10. The medical instruments supplier earned $10.50 million during the quarter, compared to analyst estimates of $10.73 million. What other stocks do shareholders of Invuity own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invuity investors own include Cornerstone Strategic Value Fund (CLM), Allena Pharmaceuticals (ALNA), Madrigal Pharmaceuticals (MDGL), Mondi (MNDI), Spero Therapeutics (SPRO), AcelRx Pharmaceuticals (ACRX), Ekso Bionics (EKSO), Exelixis (EXEL) and Fate Therapeutics (FATE). When did Invuity IPO? Invuity (IVTY) raised $48 million in an initial public offering on the week of June 15th 2015. The company issued 4,000,000 shares at a price of $12.00 per share. Piper Jaffray, Leerink Partners and Stifel served as the underwriters for the IPO and William Blair was co-manager. This page (NASDAQ:IVTY) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invuity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Invuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.